マーケットレポート詳細
内視鏡再処理の世界市場：2027年に至る製品タイプ別、エンドユーザー別予測
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 - 2027)
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年5月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文259ページになります。
- 商品コード：MAM2928
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
内視鏡再処理の世界市場規模は2022年で24億ドル、2027年に38億ドル、市場の平均年成長率は9.7%になると推測されます。
レポートは内視鏡再処理の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、エンドユーザー別市場）を中心に構成されています。また競合状況、主要企業情報（15社）、エコシステム分析、ファイブフォース分析などの分析も加味し、内視鏡再処理市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆内視鏡再処理の世界市場予測2017-2027年
・市場規模(US$)
◆製品別、市場-2027年
高水準消毒剤/試験紙
洗浄液/ワイプ
自動内視鏡リプロセッサ(AER)
<ポータビリティ別>
・スタンドアロンAER
・ポータブルAER
<タイプ別>
・単一槽型
・二槽
乾燥/保管/輸送システム
内視鏡追跡システム
その他製品
※(市場規模US$)
◆エンドユーザー別、市場-2027年
・病院
・外科手術センター/クリニック
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
・中南米
・中東アフリカ
※国地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19の影響
・規制分析
・ファイブフォース分析
・エコシステム分析
・特許分析
・価格分析
・市場シェア分析
・競合状況
◆内視鏡再処理の主要企業プロフィール動向
・CANTEL MEDICAL
・ADVANCED STERILIZATION PRODUCTS (FORTIVE)
・オリンパス株式会社
・ECOLAB
・STERIS
・GETINGE AB
・WASSENBURG MEDICAL (A MEMBER OF HOYA)
・CONMED CORPORATION
・BELIMED AG (A METALL ZUG GROUP COMPANY)
・ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL)
・CUSTOM ULTRASONICS
・STEELCO S.P.A
・BES HEALTHCARE (A DIVISION OF BES REHAB LTD)
・ARC HEALTHCARE SOLUTIONS
・METREX RESEARCH, LLC
（その他企業）
・RICHARD WOLF GMBH
・MEDALKAN
・MICRO-SCIENTIFIC, LLC
・BORER CHEMIE AG
・MEDONICA CO. LTD
・TUTTNAUER
・ATMS
・SUMMIT IMAGING, INC.
・SHINVA MEDICAL INSTRUMENT CO., LTD
・MEDICAL DEVICES GROUP SRL
（全259頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKET SEGMENTATION 34
1.3.2 GEOGRAPHIC SCOPE 34
1.3.3 YEARS CONSIDERED 35
1.4 CURRENCY 35
1.5 LIMITATIONS 35
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
・ FIGURE 1 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 KEY DATA FROM SECONDARY SOURCES 40
2.1.2 PRIMARY DATA 40
・ FIGURE 2 PRIMARY SOURCES 40
2.1.2.1 KEY DATA FROM PRIMARY SOURCES 41
2.1.2.2 KEY INDUSTRY INSIGHTS 42
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 42
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 43
・ FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BELIMED AG
(A METALL ZUG GROUP COMPANY). 44
・ FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
(SUPPLY SIDE): COLLECTIVE REVENUE OF ENDOSCOPE REPROCESSING PRODUCTS AND SERVICES 44
・ FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 45
・ FIGURE 8 TOP-DOWN APPROACH 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 47
・ FIGURE 9 DATA TRIANGULATION METHODOLOGY 47
2.4 STUDY ASSUMPTIONS 48
2.5 RISK ASSESSMENT/FACTOR ANALYSIS 48
・ TABLE 1 RISKS 48
3 EXECUTIVE SUMMARY 49
・ FIGURE 10 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2022 VS. 2027 (USD BILLION) 49
・ FIGURE 11 ENDOSCOPE REPROCESSING MARKET, BY END-USER,
2022 VS. 2027 (USD BILLION) 50
・ FIGURE 12 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2022 VS. 2027 (USD BILLION) 51
4 PREMIUM INSIGHTS 52
4.1 ENDOSCOPE REPROCESSING MARKET OVERVIEW 52
・ FIGURE 13 RISING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES TO DRIVE MARKET GROWTH 52
4.2 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2021) 53
・ FIGURE 14 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT TO DOMINATE MARKET IN 2021 53
4.3 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET 54
・ FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
・ FIGURE 16 ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 INCREASING REQUIREMENT FOR ENDOSCOPY TO DIAGNOSE
AND TREAT TARGET DISEASES 56
5.2.1.2 HIGH RISK OF ENDOSCOPE-ASSOCIATED INFECTIONS 56
5.2.1.3 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE
IN ENDOSCOPIC PROCEDURES 57
5.2.1.4 INCREASING EMPHASIS ON IMPROVING REPROCESSING GUIDELINES
BY HEALTHCARE AUTHORITIES 58
5.2.1.5 INCREASING INVESTMENTS, FUNDS, AND GRANTS TO IMPROVE HEALTHCARE INFRASTRUCTURE AND RESEARCH AREAS OF ENDOSCOPY 59
・ TABLE 2 MAJOR DEVELOPMENTS 59
5.2.1.6 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES 59
5.2.1.7 RISING FOCUS OF MEDICAL SPECIALISTS AND HEALTHCARE PROVIDERS ON SHIFTING FROM MANUAL TO AUTOMATED ENDOSCOPY REPROCESSING 60
5.2.2 RESTRAINTS 61
5.2.2.1 CONCERNS RELATED TO REPROCESSED INSTRUMENT SAFETY 61
5.2.2.2 ADVERSE EFFECTS OF CHEMICAL DISINFECTANTS 61
5.2.2.3 HIGH OVERHEAD COSTS OF ENDOSCOPY PROCEDURES WITH LIMITED REIMBURSEMENT IN DEVELOPING COUNTRIES 62
5.2.2.4 HIGH RISK OF COVID-19 TRANSMISSION DURING ENDOSCOPIC PROCEDURES 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 GROWING MEDICAL DEVICES INDUSTRY IN EMERGING ECONOMIES 63
・ FIGURE 17 MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION) 64
5.2.4 CHALLENGES 64
5.2.4.1 PREFERENCE FOR SINGLE-USE ENDOSCOPES 64
5.2.4.2 INCREASING NUMBER OF PRODUCT FAILURES AND RECALLS 65
5.2.4.3 SHORTAGE OF TRAINED PROFESSIONALS 65
5.2.4.4 LACK OF AWARENESS ASSOCIATED WITH REPROCESSING METHODS 66
5.2.4.5 INCREASING FDA RECOMMENDED MEASURES TO
REDUCE INFECTION TRANSMISSION 66
5.3 COVID-19 IMPACT ANALYSIS 67
・ FIGURE 18 PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK
BEFORE AND DURING COVID-19 67
5.4 RANGES/ SCENARIOS 68
5.4.1 ENDOSCOPE REPROCESSING MARKET 68
・ FIGURE 19 REALISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET 68
・ FIGURE 20 PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET 69
・ FIGURE 21 OPTIMISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET 69
5.5 REGULATORY ANALYSIS 70
・ TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
MEDICAL DEVICE REPROCESSING 70
5.5.1 NORTH AMERICA 70
5.5.1.1 US 70
・ FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR
REPROCESSED MEDICAL DEVICES 71
5.5.1.2 CANADA 71
・ TABLE 4 CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES 72
5.5.2 EUROPE 73
・ FIGURE 23 CE MARKING FOR REPROCESSED MEDICAL DEVICES 73
5.5.2.1 GERMANY 73
5.5.2.2 REST OF EUROPE 74
5.5.3 ASIA PACIFIC 74
5.5.3.1 JAPAN 74
5.5.3.2 AUSTRALIA 74
5.5.3.3 REST OF ASIA PACIFIC 74
5.5.4 LATIN AMERICA 75
5.5.5 MIDDLE EAST & AFRICA 75
5.6 PORTER’S FIVE FORCES ANALYSIS 75
5.6.1 THREAT FROM NEW ENTRANTS 76
5.6.2 BARGAINING POWER OF SUPPLIERS 76
5.6.3 BARGAINING POWER OF BUYERS 76
5.6.4 INTENSITY OF COMPETITIVE RIVALRY 76
5.6.5 THREAT FROM SUBSTITUTES 77
5.7 SUPPLY CHAIN ANALYSIS 77
・ FIGURE 24 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 78
5.8 VALUE CHAIN ANALYSIS 78
・ FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED
DURING MANUFACTURING AND ASSEMBLY PHASES 78
5.9 ECOSYSTEM ANALYSIS 79
・ FIGURE 26 ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS 79
5.9.1 ROLE IN ECOSYSTEM 80
・ FIGURE 27 KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET ECOSYSTEM 80
5.10 TECHNOLOGY ANALYSIS 81
5.11 KEY CONFERENCES & EVENTS IN 2022-2023 82
・ TABLE 5 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST
OF CONFERENCES & EVENTS 82
5.12 PATENT ANALYSIS 83
5.12.1 PATENT GRANTED TRENDS FOR ENDOSCOPE REPROCESSORS 84
・ FIGURE 28 PATENT GRANTED TRENDS OF AUTOMATED ENDOSCOPE REPROCESSORS, JANUARY 2011– APRIL 2022 84
・ FIGURE 29 PATENT GRANTED TRENDS OF HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011– FEBRUARY 2022 85
・ FIGURE 30 PATENT GRANTED TRENDS OF ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011– APRIL 2022 85
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS 86
・ FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AUTOMATED ENDOSCOPE REPROCESSORS PATENTS,
JANUARY 2011—APRIL 2022 86
・ FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011—APRIL 2022 87
・ FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011— APRIL 2022 88
5.13 TRADE ANALYSIS 88
5.13.1 IMPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION) 89
5.13.2 EXPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION) 89
5.13.3 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 90
5.13.4 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 90
5.14 PRICING ANALYSIS 91
・ TABLE 6 AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT 91
・ TABLE 7 AVERAGE SELLING PRICE FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY 91
・ TABLE 8 COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER 92
・ TABLE 9 TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE 93
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 93
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 93
・ FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS 93
・ TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS (%) 94
5.15.2 BUYING CRITERIA 94
・ FIGURE 35 KEY BUYING CRITERIA FOR END USERS 94
・ TABLE 11 KEY BUYING CRITERIA FOR END USERS 95
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS 95
・ FIGURE 36 REVENUE SHIFT FOR ENDOSCOPE REPROCESSING 96
6 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT 97
6.1 INTRODUCTION 98
・ TABLE 12 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 98
・ TABLE 13 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 99
6.2 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS 99
6.2.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS DEMAND 99
・ TABLE 14 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017–2020 (USD MILLION) 100
・ TABLE 15 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2021–2027 (USD MILLION) 100
6.3 DETERGENTS & WIPES 101
6.3.1 INCREASING EMPHASIS ON PRE-CLEANING METHODS
TO PROPEL SEGMENT GROWTH 101
・ TABLE 16 ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES,
BY REGION, 2017–2020 (USD MILLION) 101
・ TABLE 17 ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES,
BY REGION, 2021–2027 (USD MILLION) 102
6.4 AUTOMATED ENDOSCOPE REPROCESSORS 102
6.4.1 INCREASED EFFICIENCY OF AUTOMATED ENDOSCOPE REPROCESSORS OVER MANUAL CLEANING TO DRIVE MARKET GROWTH 102
・ TABLE 18 MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS 103
・ TABLE 19 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2017–2020 (USD MILLION) 104
・ TABLE 20 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2021–2027 (USD MILLION) 104
6.4.2 AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY 105
6.4.2.1 INTRODUCTION 105
・ TABLE 21 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2017–2020 (USD MILLION) 105
・ TABLE 22 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2021–2027 (USD MILLION) 105
6.4.2.2 STANDALONE AER 105
・ TABLE 23 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017–2020 (USD MILLION) 106
・ TABLE 24 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2021–2027 (USD MILLION) 106
6.4.2.3 POR・ TABLE AER 106
・ TABLE 25 ENDOSCOPE REPROCESSING MARKET FOR POR・ TABLE AER, BY REGION, 2017–2020 (USD MILLION) 107
・ TABLE 26 ENDOSCOPE REPROCESSING MARKET FOR POR・ TABLE AER, BY REGION, 2021–2027 (USD MILLION) 107
6.4.3 AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE 107
・ TABLE 27 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2017–2020 (USD MILLION) 108
・ TABLE 28 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2021–2027 (USD MILLION) 108
6.4.3.1 SINGLE-BASIN AER 108
・ TABLE 29 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (SINGLE BASIN) 108
6.4.3.2 DOUBLE-BASIN AER 109
・ TABLE 30 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (DUAL BASIN) 109
6.5 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS 109
6.5.1 GUIDELINES FOR DRYING, STORAGE, AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO DRIVE MARKET GROWTH 109
・ TABLE 31 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED 110
・ TABLE 32 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017–2020 (USD MILLION) 111
・ TABLE 33 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2021–2027 (USD MILLION) 111
6.6 ENDOSCOPE TRACKING SYSTEMS 112
6.6.1 RISING FOCUS ON REPROCESSING TO DRIVE SEGMENT GROWTH 112
・ TABLE 34 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2017–2020 (USD MILLION) 113
・ TABLE 35 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2021–2027 (USD MILLION) 113
6.7 OTHER PRODUCTS 114
・ TABLE 36 OTHER PRODUCTS OFFERED BY MANUFACTURERS 115
・ TABLE 37 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2017–2020 (USD MILLION) 116
・ TABLE 38 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2021–2027 (USD MILLION) 116
7 ENDOSCOPE REPROCESSING MARKET, BY END USER 117
7.1 INTRODUCTION 118
・ TABLE 39 ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 118
・ TABLE 40 ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 118
7.2 HOSPITALS 119
7.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS 119
・ TABLE 41 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2017–2020 (USD MILLION) 120
・ TABLE 42 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2021–2027 (USD MILLION) 120
7.3 AMBULATORY SURGERY CENTERS AND CLINICS 121
7.3.1 COST-EFFECTIVENESS OF AMBULATORY SURGERY CENTERS AND CLINICS TO DRIVE MARKET GROWTH 121
・ TABLE 43 NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY
CENTERS IN US, 2013–2017 121
・ TABLE 44 TOTAL AMBULATORY SURGERY CENTER PROCEDURES IN US, 2015–2021 122
・ TABLE 45 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2017–2020 (USD MILLION) 123
・ TABLE 46 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2021–2027 (USD MILLION) 123
7.4 OTHER END USERS 124
・ TABLE 47 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2017–2020 (USD MILLION) 124
・ TABLE 48 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2021–2027 (USD MILLION) 125
8 ENDOSCOPE REPROCESSING MARKET, BY REGION 126
8.1 INTRODUCTION 127
・ TABLE 49 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2017–2020 (USD MILLION) 127
・ TABLE 50 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2021–2027 (USD MILLION) 127
8.2 NORTH AMERICA 128
・ FIGURE 37 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 128
・ TABLE 51 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 129
・ TABLE 52 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION) 129
・ TABLE 53 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 130
・ TABLE 54 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 130
・ TABLE 55 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 131
・ TABLE 56 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 131
・ TABLE 57 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 131
・ TABLE 58 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 132
8.2.1 US 132
8.2.1.1 FAVORABLE REIMBURSEMENT SCENARIO TO PROPEL MARKET GROWTH 132
・ TABLE 59 MEDICARE NATIONAL AVERAGE COVERAGE FOR
OUTPATIENT PROCEDURES, 2021 132
・ TABLE 60 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 134
・ TABLE 61 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 134
・ TABLE 62 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 135
・ TABLE 63 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 135
・ TABLE 64 US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 135
・ TABLE 65 US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 136
8.2.2 CANADA 136
8.2.2.1 HIGH PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH 136
・ TABLE 66 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 137
・ TABLE 67 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 137
・ TABLE 68 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 138
・ TABLE 69 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 138
・ TABLE 70 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 139
・ TABLE 71 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 139
・ TABLE 72 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 139
8.3 EUROPE 140
・ TABLE 73 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 140
・ TABLE 74 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION) 140
・ TABLE 75 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 141
・ TABLE 76 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 141
・ TABLE 77 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 142
・ TABLE 78 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 142
・ TABLE 79 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 142
・ TABLE 80 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 143
8.3.1 GERMANY 143
8.3.1.1 INCREASED SURGICAL PROCEDURES TO PROPEL MARKET GROWTH 143
・ TABLE 81 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 144
・ TABLE 82 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 144
・ TABLE 83 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 145
・ TABLE 84 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 145
・ TABLE 85 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 146
・ TABLE 86 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 146
・ TABLE 87 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 146
8.3.2 UK 147
8.3.2.1 INCREASING USE OF ENDOSCOPY PROCEDURES TO DRIVE MARKET GROWTH 147
・ FIGURE 38 MEAN PERCENTAGE CHANGE IN ENDOSCOPE
PROCEDURE NUMBERS BETWEEN 2017 AND 2019 148
・ TABLE 88 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 149
・ TABLE 89 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 149
・ TABLE 90 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 150
・ TABLE 91 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 150
・ TABLE 92 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 150
・ TABLE 93 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 151
8.3.3 FRANCE 151
8.3.3.1 INCREASING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH 151
・ TABLE 94 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 152
・ TABLE 95 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 152
・ TABLE 96 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 153
・ TABLE 97 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 153
・ TABLE 98 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 154
・ TABLE 99 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 154
・ TABLE 100 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 154
8.3.4 ITALY 155
8.3.4.1 GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH 155
・ TABLE 101 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 155
・ TABLE 102 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 156
・ TABLE 103 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 156
・ TABLE 104 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 157
・ TABLE 105 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 157
・ TABLE 106 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 157
・ TABLE 107 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 158
8.3.5 SPAIN 158
8.3.5.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 158
・ TABLE 108 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 159
・ TABLE 109 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 159
・ TABLE 110 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 160
・ TABLE 111 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 160
・ TABLE 112 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 160
・ TABLE 113 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 161
8.3.6 REST OF EUROPE 161
・ TABLE 114 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 162
・ TABLE 115 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 162
・ TABLE 116 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 163
・ TABLE 117 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 163
・ TABLE 118 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION) 163
・ TABLE 119 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION) 164
8.4 ASIA PACIFIC 164
・ FIGURE 39 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 165
・ TABLE 120 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 166
・ TABLE 121 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION) 166
・ TABLE 122 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 167
・ TABLE 123 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 167
・ TABLE 124 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 168
・ TABLE 125 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 168
・ TABLE 126 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 168
・ TABLE 127 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 169
8.4.1 JAPAN 169
8.4.1.1 INCREASING USE OF ENDOSCOPES TO DRIVE MARKET GROWTH 169
・ TABLE 128 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 170
・ TABLE 129 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 171
・ TABLE 130 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 171
・ TABLE 131 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 172
・ TABLE 132 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 172
・ TABLE 133 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 172
8.4.2 CHINA 173
8.4.2.1 RISING PREVALENCE OF CANCER TO INCREASE ENDOSCOPIC PROCEDURES 173
・ TABLE 134 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 173
・ TABLE 135 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 174
・ TABLE 136 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 174
・ TABLE 137 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 175
・ TABLE 138 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 175
・ TABLE 139 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 175
・ TABLE 140 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 176
8.4.3 INDIA 176
8.4.3.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 176
・ TABLE 141 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 177
・ TABLE 142 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 177
・ TABLE 143 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 178
・ TABLE 144 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 178
・ TABLE 145 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 179
・ TABLE 146 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 179
・ TABLE 147 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 179
8.4.4 REST OF ASIA PACIFIC 180
・ TABLE 148 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC COUNTRIES 180
・ TABLE 149 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 181
・ TABLE 150 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 181
・ TABLE 151 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 182
・ TABLE 152 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 182
・ TABLE 153 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 182
・ TABLE 154 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 183
8.5 REST OF THE WORLD 183
・ TABLE 155 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION) 183
・ TABLE 156 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021–2027 (USD MILLION) 184
・ TABLE 157 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 184
・ TABLE 158 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 185
・ TABLE 159 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 185
・ TABLE 160 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 186
・ TABLE 161 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 186
・ TABLE 162 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 186
8.5.1 LATIN AMERICA 187
8.5.1.1 RISING PREVALENCE OF INFECTIONS DUE TO ENDOSCOPY-RELATED PROCEDURES TO SUPPORT MARKET GROWTH 187
・ TABLE 163 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
・ TABLE 164 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
・ TABLE 165 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
・ TABLE 166 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 189
・ TABLE 167 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 189
・ TABLE 168 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 190
・ TABLE 169 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 190
・ TABLE 170 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION) 190
・ TABLE 171 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION) 191
8.5.2 MIDDLE EAST & AFRICA 191
8.5.2.1 INTRODUCTION OF REGULATORY FRAMEWORKS FOR MEDICAL EQUIPMENT REPROCESSING TO DRIVE MARKET GROWTH 191
・ TABLE 172 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 192
・ TABLE 173 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2017–2020 (USD MILLION) 192
・ TABLE 174 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2021–2027 (USD MILLION) 193
・ TABLE 175 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 193
・ TABLE 176 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 194
・ TABLE 177 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 194
・ TABLE 178 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 194
9 COMPETITIVE LANDSCAPE 195
9.1 OVERVIEW 195
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 195
・ TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS 195
9.3 REVENUE ANALYSIS 196
・ FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE
REPROCESSING MARKET 197
9.4 MARKET SHARE ANALYSIS 197
・ FIGURE 41 ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020 198
・ TABLE 180 ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION 198
9.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 200
9.5.1 STARS 200
9.5.2 EMERGING LEADERS 200
9.5.3 PERVASIVE PLAYERS 200
9.5.4 PARTICIPANTS 200
・ FIGURE 42 VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET 201
9.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 202
9.6.1 PROGRESSIVE COMPANIES 202
9.6.2 STARTING BLOCKS 202
9.6.3 RESPONSIVE COMPANIES 202
9.6.4 DYNAMIC COMPANIES 202
・ FIGURE 43 ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020 203
9.6.4.1 COMPETITIVE BENCHMARKING 204
・ TABLE 181 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUP/SMES 204
・ TABLE 182 ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES] 205
9.7 COMPANY FOOTPRINT 206
・ TABLE 183 COMPANY FOOTPRINT 206
・ TABLE 184 COMPANY PRODUCT FOOTPRINT 207
・ TABLE 185 COMPANY GEOGRAPHICAL FOOTPRINT 208
9.8 COMPETITIVE SCENARIO AND TRENDS 209
9.8.1 DEALS 209
・ TABLE 186 DEALS, JANUARY 2019- APRIL 2022 209
9.8.2 PRODUCT LAUNCHES & APPROVALS 210
・ TABLE 187 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019- APRIL 2022 210
9.8.3 EXPANSIONS 211
・ TABLE 188 EXPANSIONS, JANUARY 2019- APRIL 2022 211
10 COMPANY PROFILES 212
10.1 KEY PLAYERS 212
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
10.1.1 CANTEL MEDICAL 212
・ TABLE 189 CANTEL MEDICAL: BUSINESS OVERVIEW 212
・ FIGURE 44 CANTEL MEDICAL: COMPANY SNAPSHOT (2020) 213
10.1.2 ADVANCED STERILIZATION PRODUCTS (FORTIVE) 217
・ TABLE 190 ADVANCED STERILIZATION PRODUCTS (FORTIVE): BUSINESS OVERVIEW 217
・ FIGURE 45 ADVANCED STERILIZATION PRODUCTS (FORTIVE):
COMPANY SNAPSHOT (2020) 218
10.1.3 OLYMPUS CORPORATION 221
・ TABLE 191 OLYMPUS CORPORATION: BUSINESS OVERVIEW 221
・ FIGURE 46 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020) 222
10.1.4 ECOLAB 225
・ TABLE 192 ECOLAB: BUSINESS OVERVIEW 225
・ FIGURE 47 ECOLAB: COMPANY SNAPSHOT (2021) 226
10.1.5 STERIS 229
・ TABLE 193 STERIS: BUSINESS OVERVIEW 229
・ FIGURE 48 STERIS: COMPANY SNAPSHOT (2020) 230
10.1.6 GETINGE AB 234
・ TABLE 194 GETINGE AB: BUSINESS OVERVIEW 234
・ FIGURE 49 GETINGE AB: COMPANY SNAPSHOT (2021) 235
10.1.7 WASSENBURG MEDICAL (A MEMBER OF HOYA) 239
・ TABLE 195 WASSENBURG MEDICAL (A MEMBER OF HOYA): BUSINESS OVERVIEW 239
・ FIGURE 50 WASSENBURG MEDICAL (A MEMBER OF HOYA):
COMPANY SNAPSHOT (2020) 239
10.1.8 CONMED CORPORATION 241
・ TABLE 196 CONMED CORPORATION: BUSINESS OVERVIEW 241
・ FIGURE 51 CONMED CORPORATION: COMPANY SNAPSHOT (2021) 242
10.1.9 BELIMED AG (A METALL ZUG GROUP COMPANY) 243
・ TABLE 197 BELIMED AG (METALL ZUG GROUP COMPANY): BUSINESS OVERVIEW 243
・ FIGURE 52 BELIMED AG (METALL ZUG GROUP COMPANY): COMPANY SNAPSHOT (2021) 244
10.1.10 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL) 246
・ TABLE 198 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): BUSINESS OVERVIEW 246
・ FIGURE 53 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL):
COMPANY SNAPSHOT (2020) 246
10.1.11 CUSTOM ULTRASONICS 249
・ TABLE 199 CUSTOM ULTRASONICS: BUSINESS OVERVIEW 249
10.1.12 STEELCO S.P.A 250
・ TABLE 200 STEELCO S.P.A: BUSINESS OVERVIEW 250
10.1.13 BES HEALTHCARE (A DIVISION OF BES REHAB LTD) 252
・ TABLE 201 BES HEALTHCARE: BUSINESS OVERVIEW 252
10.1.14 ARC HEALTHCARE SOLUTIONS 253
・ TABLE 202 ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW 253
10.1.15 METREX RESEARCH, LLC 254
・ TABLE 203 METREX RESEARCH. LLC: BUSINESS OVERVIEW 254
10.2 OTHER PLAYERS 255
10.2.1 RICHARD WOLF GMBH 255
・ TABLE 204 RICHARD WOLF GMBH: BUSINESS OVERVIEW 255
10.2.2 MEDALKAN 255
・ TABLE 205 MEDALKAN: BUSINESS OVERVIEW 255
10.2.3 MICRO-SCIENTIFIC, LLC 256
・ TABLE 206 MICRO-SCIENTIFIC, LLC: BUSINESS OVERVIEW 256
10.2.4 BORER CHEMIE AG 256
・ TABLE 207 BORER CHEMIE AG: BUSINESS OVERVIEW 256
10.2.5 MEDONICA CO. LTD 257
・ TABLE 208 MEDONICA CO. LTD: BUSINESS OVERVIEW 257
10.2.6 TUTTNAUER 257
・ TABLE 209 TUTTNAUER: BUSINESS OVERVIEW 257
10.2.7 ATMS 258
・ TABLE 210 ATMS: BUSINESS OVERVIEW 258
10.2.8 SUMMIT IMAGING, INC. 258
・ TABLE 211 SUMMIT IMAGING, INC.: BUSINESS OVERVIEW 258
10.2.9 SHINVA MEDICAL INSTRUMENT CO., LTD 259
・ TABLE 212 SHINVA MEDICAL INSTRUMENT CO., LTD: BUSINESS OVERVIEW 259
10.2.10 MEDICAL DEVICES GROUP SRL 259
・ TABLE 213 MEDICAL DEVICES GROUP SRL: BUSINESS OVERVIEW 259
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11 APPENDIX 260